Researchers focus on genetic mutations for Crohn's disease treatment

04/27/2010 | Wall Street Journal, The

U.S. researchers are examining genetic mutations linked to Crohn's disease, ulcerative colitis and other irritable bowel conditions in hopes of developing personalized treatments based on stem cells. They hope to use induced pluripotent stem cells to repair the NOD2 genetic mutation that is related to Crohn's.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care